z-logo
Premium
Using real‐world safety data in regulatory approval decisions: Sotagliflozin and the risk of diabetic ketoacidosis
Author(s) -
Fralick Michael,
Kesselheim Aaron S
Publication year - 2020
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.4994
Subject(s) - medicine , diabetic ketoacidosis , food and drug administration , pharmacoepidemiology , ketoacidosis , medical emergency , intensive care medicine , diabetes mellitus , pharmacology , medical prescription , type 1 diabetes , endocrinology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom